Developing Leadership Effectiveness

MACRO ENVIRONMENT

▪ Globalisation leading to increased mobility and cultural complexity

▪ Increasing need to balance agile response to global health crises, whilst maintaining a focus on ‘business as usual’ ▪ Legal, regulatory and compliance restrictions leading to greater reliance on big data management

▪ Technology adoption impacting on processes and people

▪ Changing economic landscape as markets adjust to the consequences of Brexit and international economic conditions

IDENTIFYING THE CHALLENGES

MICROENVIRONMENT

▪ Patent ‘cliffs’ leading to genericised trademarks

▪ Mergers & acquisitions due to market fragmentation and consolidation

▪ Pioneer Therapies – with the launch of next generation biologic therapies, cutting edge science needs to meet commercial reality ▪ Pressure on research and development costs as clinical development evolves, with a focus on speciality products in closely defined patient populations ▪ Offshoring, outsourcing and partnerships resulting in a shift of organisational and operational structures

▪ Complex stakeholder networks requiring skilled management

▪

Growing influence of patient voice

▪ Multi-generational, multi-locational, multi-discipline teams

6

www.primeast.com T:+44 (0) 1423 531083 (EMEA) | + 1 609 6428821 (USA)